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Introduction
Iron deficiency is the most frequently observed nutritional disorder 
in athletes performing aerobic exercise and resistance training 
(1,2), especially affecting women (3,4) and adolescents (2,5). 
Estimates of the incidence of this disorder in men and women 
athletes run at 11% and 35%, respectively (6,7). Studies have 
shown that physical exercise modifies several variables related 
to iron metabolism (8), and mean haemoglobin and ferritin 
concentrations have been generally found to be lower in athletes 
than in untrained subjects (9,10). Significant variations have also 
been detected in such variables during the course of a sports 
season (11). 
Among the roles played by iron, we should highlight oxygen 
transport and storage (forming part of haemoglobin and 
myoglobin), a role in the electron transport chain and DNA 
synthesis, and as a catalyst in free radical production from oxygen 
as a beneficial pro-oxidant function (12,13,14). The nature of these 
functions makes iron the most important factor related to human 
sports performance. Iron depletion has the following physiological 
effects: it reduces performance capacity and causes fatigue, 
exercise intolerance, altered immune function, short bursts of 
attention loss, irritability, loss of visual perception, impaired 
temperature regulation in cold, and a reduced capacity to adapt 
to high altitudes (15,16,17,18,19). Hence, to a large extent, good 
sports performance will depend on maintaining adequate iron 
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Given the multiple functions of iron in the body, any state of iron deficiency will induce a series of secondary effects that could compromise sports 
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inflammation and physical exercise. Given the important role played by iron regulatory mechanisms in physical performance, this report reviews 
our current understanding of the physiological response of hepcidin to different sports intensities and modalities. Turk Jem 2014; 18: 84-91
Key words: Iron, iron deficiency, inflammation, cytokines, aerobic exercise, hepcidin
Raúl Domínguez, Davinia Vicente-Campos*, Davinia Vicente-Campos**, José Chicharro**
Alfonso X University Faculty of Physical Activity and Sports Sciences, Villanueva de la Cañada, Madrid, Spain
*Francisco de Vitoria University Faculty of Physical Activity and Sports Sciences, Pozuelo de Alarcon, Madrid, Spain
**Complutense University, FEBIO Group, Madrid, Spain
Egzersize Hepsidin Yanıtı: Derleme
Hepcidin Response to Exercise: A Review
DOI: 10.4274/tjem.2438
85Turk Jem 2014; 18: 84-91
Domínguez et al.
Hepcidin Response to Exercise: A Review
levels. A major goal for any athlete should therefore be to keep 
iron levels stable throughout an entire sports season (20).
Although attempts have been made to relate the intake of iron in 
athletes to their body iron stores, numerous studies have detected 
no such correlation (21,22,23), mainly because absorption 
mechanisms may be affected by different physical activities (21). 
Thus, as a negative iron regulator in the duodenum (24) and 
the main iron metabolism regulator (25,26,27), understanding 
hepcidin response associated with physical exercise may help 
explain anaemia and iron deficiency that so frequently affect 
athletes, especially during resistance training (28). 
In this report, we update the current state of the topic by reviewing 
the literature addressing the hepcidin response associated with 
exercise.
Physiology of Hepcidin 
Hepcidin is a peptide hormone produced mainly by hepatocytes 
(29,30) and was given this name because its mRNA was found to 
be highly expressed in the liver and it showed weak microbicidal 
activity in vitro (31). Up to three different isoforms of hepcidin exist 
each with four disulphide bridges: one consisting of 25 amino 
acids (hepcidin-25) (27) and two smaller isoforms hepcidin-22 
and hepcidin-20, comprising 22 and 20 amino acids, respectively 
(32,33). Blood and urine concentrations of hepcidin-20 and 
hepcidin-22 are generally low, and higher levels are only observed 
in some physiological processes associated with elevated 
hepcidin-25 concentrations, such as acute myocardial infarction, 
sepsis, anaemia of chronic disease, metabolic syndrome and 
chronic renal disease (34,35,36,37,38,39). 
Mechanism of Action 
According to Ganz (40), the main function of hepcidin is related 
to immunity since iron is essential for the survival of invading 
pathogens (41). In effect, a positive relationship has been observed 
between bacterial virulence and iron availability (42). Hepcidin 
regulates iron by hindering its absorption (30,43,44,45). Several 
studies have shown that  overexpression of hepcidin leads to 
iron deficiency both in humans (46) and mice (47), while hepcidin 
deficiency gives rise to excessive deposition of iron (44,48). Thus, 
it seems that both iron deficiency (49) and iron overload (48) are 
influenced to a large extent by an individual’s hepcidin response.
Hepcidin’s mechanism of action is based on degradation of 
ferroportin (50,51,52). In vitro, it has been observed that when 
hepcidin binds to its receptor ferroportin, the two proteins are 
degraded via endocytosis in lysosomes (53,54). As it is well-
known, ferroportin exports iron from macrophages and the 
basolateral membrane of duodenal enterocytes (55,56,57). 
Hence, hepcidin -besides reducing the absorption of dietary iron- 
also blocks the recycling of iron released by haemolysis (53,54). 
Further, although still unconfirmed, it appears that hepcidin also 
exerts some effects on other means of iron transport, such as the 
divalent metal ion transporter (Figure 1).
Hepcidin Determination 
No reference standard exists to determine hepcidin levels and 
neither is there a valid calibrator for its measurement, hindering 
the comparison of results emerging from the studies conducted 
to date on this peptide (27). Notwithstanding, there appears to 
be no great difference in the methods usually employed, and 
for both serum and urine samples, mass spectrometry and 
immunochemical techniques are equally effective (58). We should, 
however, bear in mind the following basic principles:
- Hepcidin determination does not accurately reflect serum levels 
although correlation exists between the two variables both in 
healthy individuals and subjects with an iron metabolism disorder 
(27). We should also consider that being highly susceptible to 
oxidation (59), hepcidin-25 cannot be distinguished from the 
other isoforms of hepcidin in urine samples (58). Further aspects 
that impair the interpretation of urine hepcidin measurements 
are: their dependence on the glomerular filtration rate, tubular 
reabsorption and on the hepcidin production capacity of tubular 
epithelial cells (60). 
- Serum hepcidin concentrations are affected by circadian rhythm 
(61,62,63,64,65). No differences have been detected according to 
age in men (63), nor according to sex (34,61,62,64,65,66), with 
the exception of women of fertile age. This population subset 
shows lower hepcidin levels than both postmenopausal women 
and men of the same age range (63). Good correlation has been 
reported between serum hepcidin and ferritin levels (63).
Regulating Hepcidin Synthesis
Given hepcidin’s main role as a regulator of body iron homeostasis 
(67), in vitro studies have suggested the presence of iron sensors 
in hepatocytes along with the transduction apparatus required 
to modulate hepcidin synthesis (68). The different mechanisms 
controlling hepcidin synthesis proposed so far are: 
a) Iron Status 
Circulating transferrin can be detected as a hepatocellular 
complex, including the transferrin receptor protein transferrin 
1 (TfR1), transferrin receptor protein 2 (TfR2) and human 
hemochromatosis protein (HFE). It has been proposed that 
reduced abundance of TfR2 and HFE receptors will lead to a drop 
Figure 1. Mechanism of action of hepcidin. Hepcidin regulation of 
body iron. Hepcidin is released by hepatocytes into the circulation. Here 
it exerts its effects on serum iron levels by inhibiting iron absorption in 
the small intestine and iron release from macrophages, which recycle 
iron from senescent erythrocytes, by binding to its receptor ferroportin 
causing its degradation. Hepcidin only responds to iron when it is bound 
to its plasma transport protein transferrin. 
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in hepcidin levels via extracellular signals mediated by kinases 
(ERK/MAPK) and bone morphogenetic protein/Drosophila (BMP/
SMAD) (27). This regulation of hepcidin synthesis serves to explain 
why serum hepcidin levels correlate negatively with transferrin 
levels (63,69). Accordingly, individuals with low total body iron 
levels show high hepcidin concentrations (70), while iron overload 
has been linked to low hepcidin concentrations (48).
In an effort to correlate serum ferritin concentrations with hepcidin 
response to iron supplementation, Borrione et al. (71) stratified a 
group of athletes according to their serum ferritin levels into: < 20 
µg/dl; 20-30 µg/dl; 30-50 µg/dl or > 50 µg/dl. The results of this 
study revealed that subjects in the group featuring levels lower 
than 30 µg/dl of serum ferritin showed a diminished hepcidin 
response compared to the remaining groups. Thus, it seems 
that this level of 30 µg/dl of serum ferritin is the threshold below 
which iron reserves play an important role in regulating hepcidin 
synthesis. 
b) Erythropoietic Demands 
It has been proposed that stimulation of the bone marrow to 
upregulate erythropoiesis leads to increased iron absorption, 
driven by a reduced hepcidin response (40). In a cross-sectional 
study designed to obtain reference hepcidin values, it was 
observed that premenopausal women with higher erythropoietic 
demands due to menstrual blood loss showed significantly lower 
hepcidin levels than postmenopausal women (63). Similarly, other 
authors have reported that erythropoiesis inducing agents reduce 
hepcidin production (72,73).
The induction of erythropoietin has also been linked to a drop in 
hepcidin levels. Thus,  administration of testosterone (enhancing 
erythropoiesis) to mice blocks hepcidin mRNA synthesis, which 
in turn, leads to increased iron import into red blood cells (74). 
Hence, the intake of erythropoiesis stimulating agents seems to 
reduce the hepcidin response (72,73). This is also true of anabolic 
substances (74), indicating a mechanism of action that improves 
aerobic performance in athletes consuming such performance-
enhancing drugs.
c) Hypoxia
Hypoxia seems to be another factor able to modulate hepcidin, 
diminishing its serum levels (75,76). In exercise physiology, 
exposure to a high altitude has been the classic method of 
improving erythropoietin levels (EPO), as well as enhancing 
reticulocytes, haematocrit and haemoglobin (77,78,79). 
However, it is claimed that for a beneficial effect on the different 
haematological variables, a set of conditions has to be met 
including exposure to altitudes higher than 2000-2200 metres for 
at least 12 hours per day (80).
Serum testosterone levels are thought to be one of the factors 
responsible for the haematological modifications produced at 
high altitude. Several studies have observed elevated testosterone 
levels after a period at high altitude (81,82), probably attributable 
to its attenuating effects on altitude-related hyperventilation 
and respiratory alkalosis. Based on the finding that exogenous 
testosterone intake reduces hepcidin levels (83) by interfering 
with mRNA synthesis (74), it could be speculated that the hypoxia 
response of improved haematological indicators is due in part 
to a decrease in hepcidin synthesis as a consequence of the 
testosterone response to high altitude. 
d) Dietary Iron 
As may be predicted, iron ingested through diet may also affect 
the hepcidin response such that a transient increase in its urine 
levels is produced 4-8 hours after iron intake (34,62). In subjects 
given dietary iron supplements, Lin et al. (84) observed an increase 
in urine hepcidin clearance proportional to serum transferrin 
saturation. 
e) Inflammation
Inflammation has been proposed as another factor that 
modulates the synthesis of hepcidin (85). Interleukin-6 (IL-6) is 
thought to play an important role in this process (86,87,88,89), 
along with BMP-2 (90).
In many chronic diseases, moderate anaemia is produced by 
inflammation. This anaemia of chronic disease is characterized 
by low serum iron concentrations (91). In patients on dialysis, 
alterations have been observed in levels of hepcidin, interleukin-6 
and C-reactive protein (92). These same modifications have 
been observed in acute stage malaria (93), tuberculosis (94), 
inflammatory disorders (62,95), multiple myeloma (90), Hodgkin’s 
disease (96), Castleman’s disease (88), and in some patients with 
tumours (97).
Obesity is another disorder in which there is inflammation (98) 
and, a direct relationship has been noted between obesity and 
anaemia (99). In a group of morbidly obese subjects, it was 
observed that a reduction in the body mass index of 47.5 kg/m2 
to 39.5 kg/m2 led to improved inflammation variables as well as 
hepcidin and haemoglobin levels and haematocrit (100). 
f) Exercise
Exercise affects several of the factors mentioned above given; it 
promotes erythropoiesis (101) and induces an acute inflammatory 
response -similar to that observed in infection or inflammatory 
states (102). It has also been well established that free iron levels 
rise during post-exercise recovery (103,104,105,106,107,108,109). 
In the pursuit of ergogenic effects, athletes often take iron 
supplements (110,111,112). In addition, several studies have shown 
that exercise affects the hepcidin response increasing its synthesis 
or release (3,4,41,113,114,115,116,117,118,119,120).
Since inflammation is one of the factors that mediate the hepcidin 
response (34,86,88,89) and given that exercise directly affects 
cytokine levels (121), it has been proposed that the hepcidin 
response to exercise is a consequence of the inflammatory and 
haemolytic state associated with exercise (122,123). Although 
the regulation of hepcidin synthesis by means of modulating the 
levels of the variables related to inflammation has been confirmed 
in patients with chronic inflammatory processes (100), it has not 
been possible to reproduce this response following exercise 
(41,118). Recently, Sim et al. (119) observed differences in serum 
levels of interleukin-6 when running at 85% VO2max versus the 
same intensity and volume of exercise performed on a cycle 
ergometer, though no changes in hepcidin levels were observed. 
These results suggest that other factors associated with physical 
exercise act as precursors of the hepcidin response to exercise, 
and it is unlikely that the inflammatory response induced by 
exercise plays a major contributing role. 
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Hepcidin Response to Exercise 
Roecker et al. (117) were the first to report changes in urine hepcidin 
levels in women who had completed a marathon. The main 
findings of studies analysing the urine and/or serum hepcidin 
response to different exercise protocols are summarized in Tables 
1 and 2. The main observation in all these investigations, except 
for the study by Troadec et al. (120), is that hepcidin levels rise 
significantly after exercise (3,4,41,113,114,115,116,117,118,119,120). 
Below we summarize the results obtained from different studies 
that have examined the effects of several exercise-related 
variables on the hepcidin response.
a) Exercise Intensity 
- An intensity of exercise corresponding to 60% of the heart rate 
reserve or under does not seem to be associated with a significant 
increase in blood or urine hepcidin levels as a response to 
exercise (120).
- Exercise conducted at an intensity corresponding to 65% of 
VO2max seems to be linked to an increased serum hepcidin 
concentration (113,119).
- Interval exercise performed at 85% VO2max does not produce 
a greater response of serum hepcidin than that recorded for a 
continuous exercise protocol at 65% VO2max (113).
- The same exercise volume (10 km) performed continuously at 
a relative intensity of 70% VO2max induces a reduced response 
compared to the same volume performed at 90%-95% VO2max in 
intervals (114). In this study, it was also observed that while at the 
lower intensity (70% VO2max) hepcidin levels returned to normal 
after 12 hours, in the high intensity (90%-95% VO2max) elevated 
levels of the hormone persisted for 24 hours.
In summary, exercise performed at relative intensities of 65% 
VO2max or greater induces an increase in serum hepcidin levels 
(113,119), with maximum levels reached when intensities approach 
the individual’s VO2max (90%-95% VO2max) (114). 
b) Volume
In the only study that has examined the hepcidin response to 
training volume, it was observed that 120 minutes of exercise 
performed at a relative intensity of 65% VO2max on a treadmill by 
physically active women triggered a significantly higher response 
Table 1. Studies examining the acute hepcidin response to exercise in urine
Reference Subjects Experimental 
conditions (C) 
Procedure Main results
Roecker et al. 
(116)
14 female runners Marathon Pre and post-run, 24 h of 
recovery.
Hepcidin
Hepcidin increased at 24 h of recovery*.
6/14 classified as non-responders.




C1. 10 km at 70% 
VO2max.
C2. 10 km at 70% 
VO2max + 10 x 1 km 
at 90% VO2max (12 h 
recovery).
Pre, post-run and 3 h, 24 
h of recovery.
Hepcidin, IL-6, serum 
ferritin, SF, Hapt. 
Hepcidin increased at 3 h of recovery*, IL-6 post-run* and 
3 h of recovery*. Greatest increases produced in 10 x 1 at 
90% VO2max. No cumulative effect.
Fes*, Fe* and Hapt* increased in post-run and 3 h 
of recovery (same as hepcidin and IL-6), but with a 
cumulative effect.
Peeling et al. 
(114)
10 trained male 
runners
C1. 10 km at 75-80% 
VO2max on grass.
C2. 10 km at 75-80% 
VO2max on asphalt.
C3. 10 x 1 km at 
90-95% VO2max  on 
grass.
Pre, post-run, 3 h, 24 h of 
recovery.
Hepcidin, IL-6; free Hb; 
Hapt.
Hepcidin increased at 3h of recovery*. No differences 
between groups.
IL-6 and free Hb: increases post-run*, no differences 
between C1 and C2, but C3 showed an increase * versus 
C1 and C2.
Hapt: post-run reduction*.
Peeling et al. 
(115)
11 trained male 
runners
60´ Cr: 15´ at 75-80% 
peak HR + 45´ at 
85%-90% peak HR.
Pre, post-run, 3 h, 6 h, 12 
h, 24 h of recovery. 
Hepcidin, IL-6, PCR, 
serum ferritin, serum Fe.
Hepcidin: increases at 3 h*, 6 h*, 12 h* and at 24 h of 
recovery*. Peak at 3 h and 6 h.
IL-6: increased at post-run* and 3 h of recovery*. Post 
peak.
CRP: increased at 6 h*, 12 h* and 24 h of recovery*. Peak 
at 24 h of recovery.
Ferritin and serum Fe: increased at post-run *. 3 h of 
recovery* lowest vs Pre.
Troadec et al. 
(119)
14 sedentary men 45´ HRR cycle 
ergometer.
Pre, post-exercise, 0.5 h, 
1 h, 2 h, 4 h, 6 h, 12 h, 24 
h of recovery.
Hepcidin, IL-6, serum 
ferritin, serum Fe, Hapt, 
CRP.
No changes detected in any variable examined.
Studies examining the acute hepcidin response to exercise in urine. Cr: continuous running, HR: heart rate, Fe: iron; h: hour, Hapt: haptoglobin, Hb: haemoglobin,
Il-6: interleukin-6, CRP: C-reactive protein, HRR: heart rate reserve, *: statistical significance (p<0.05)
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to that observed by the same women performing the same 
intensity of exercise (65% VO2max) for a duration of 60 minutes (113). 
These results suggest that training volume may also influence the 
hepcidin response to exercise.
c) Exercise Modality
To determine if the modality of aerobic resistance exercise could 
affect the hepcidin response, Sim et al. (119) compared this 
response in a group of triathletes performing two forms of exercise 
(cycle ergometry vs running) at two different relative intensities 
(65% VO2max vs 85% VO2max). Results revealed no significant 
differences according to exercise modality or intensity despite the 
detection of some differences in serum iron or interleukin-6 levels. 
In a study performed in runners, Peeling et al. (115) compared 
the hepcidin response to footstrike as a cause of haemolysis 
in a protocol carried out at a fixed intensity of 70% VO2max on 
different running surfaces (grass vs. asphalt). Results indicated no 
significant differences in serum hepcidin levels between the two 
conditions. 
Thus, the limited data available suggest that neither the exercise 
modality (running vs cycling) nor the running surface (grass vs. 
asphalt) significantly affect the hepcidin response to exercise.  
Adaptations of the Hepcidin Response to Exercise 
Although attractive, the working hypothesis suggesting a possible 
relationship between modified hepcidin levels and the onset of 
anaemia or iron deficiency in athletes (28) has not yet provided 
conclusive results, and few studies have addressed this hypothesis 
to date (3,4). In an initial study, Auersperger et al. (3) investigated 
the effects of long-term endurance exercise on hepcidin 
concentrations and inflammation and iron status parameters. 
These authors designed a training protocol consisting of two 
3-week progressive overload periods, each followed by a week’s 
recovery and runners were assigned to either a continuous or 
interval training group. As the study’s main finding, significant 
correlation (p<0.05) was detected between total body iron levels 
and C-reactive protein or serum hepcidin concentrations. Also, 
higher hepcidin levels were observed after the first/second 
overload period compared to baseline and a significant decrease 
was produced after the first/final recovery period. In a later study 
by the same authors (4), an increased incidence of modified 
iron metabolism-related variables was noted in response to a 
similar training program (from 5/10 to 7/10), including reduced 
Turk Jem 2014; 18: 84-91
Domínguez et al.
Hepcidin Response to Exercise: A Review
Table 2. Studies examining the acute hepcidin response to exercise in serum
Reference Subjects Experimental conditions (C) Procedure Main results
Troadec et al. 
(119)
14 sedentary men 45´ HRR cycle ergometer Pre, post-exercise, 0.5 h, 1 
h, 2 h, 4 h, 6 h, 12 h, 24 h 
of recovery.
Hepcidin, IL-6, serum 
ferritin, serum Fe, Hapt, 
CRP.
No change* in any variable examined.
Robson-Ansley 
et al. (41)
9 trained men 120´ Cr at 60% VO2max+5 
km trial C1. Personalized 
hydration using a drink 
enriched with CH.
C2. Control.
Pre, post-run, 24 h of 
recovery.
Hepcidin, IL-6, serum Fe.
Hepcidin: elevated in C1 and C2 post-run*, no 
differences between groups.
IL6: increase post-run* and C2* greater than C1.
Sim et al. (117) 11 highly-trained 
triathletes 
90´ Cr at 75% VO2max.
C1. Personalized hydration 
using a drink enriched with 
CH. C2. Control.
Pre, post-run, 3 h, 24 h of 
recovery.
Hepcidin; IL-6; free Hb; 
serum ferritin, serum Fe; 
Trans.
Hepcidin and IL-6: post-run increase*, no 
differences between C1 and C2.
Hapt: post decrease*.
Free Hb: post decrease*.
Serum ferritin, serum Fe and Trans: post-run 
increase* and decrease 24 h of recovery* vs 
Pre.
Newlin et al. 
(112)
12 physically active 
women
C1. 60´ Cr at 65% VO2max.
C2. 120´Cr at 65% VO2max.
Pre, post-run, 3 h, 6 h, 9 h, 
24 h of recovery.
Hepcidin; IL-6.
Hepcidin: increases post-run* and 3 h of 
recovery*. C2 greater* vs C1.
IL-6: post-run increase*.
Sim et al. (118) 10 highly-trained 
triathletes
C1. 60´ Cr at 60-65% peak 
VO2. C2. 60´ cycle ergometer 
at 60%-65% peak VO2.
Pre, post-exercise, 3 h of 
recovery.
Hepcidin; IL-6; serum 
ferritin; serum Fe.
Hepcidin: post-exercise increase* in all groups 
with no differences between groups.
IL-6: post-exercise increase* in all groups and 
increase* in C4 versus C3.
Serum ferritin: post increase* in C3 and C4 
versus C1 and C2.
Serum Fe: post increase* in C1, C3 and C4.
Studies examining the acute hepcidin response to exercise in serum. Cr: continuous running, HR: heart rate, Fe: iron; h: hour, Hapt: haptoglobin, Hb: haemoglobin,
CH: carbohydrates, Il-6: interleukin-6, CRP: C-reactive protein, Trans: transferrin, HRR: heart rate reserve, *: statistical significance (p<0.05)
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serum hepcidin concentrations at the end of the study. This finding 
was attributed to a need to increase iron reabsorption to avoid 
compromising iron stores. However, it was observed that mean 
serum ferritin levels in the group of subjects without iron deficiency 
was 28 µg/dl. According to Borrione et al. (71), beyond 30 µg/
dl of serum ferritin, the hepcidin response to dietary iron and 
probably also to exercise may be modified. Hence, the group 
initially classified as “without iron deficiency” could be considered 
equally deficient in physiological terms.
Among the limitations of studies addressing hepcidin adaptations 
to exercise, we should mention that if baseline samples are taken 
after 24 h of rest following exercise, hepcidin concentrations are 
likely to be normal considering that it is an acute phase hormone. 
Conclusions
- The hepcidin response to exercise seems to be dependent on a 
minimum intensity of exercise (∼65% VO2max), with maximal levels 
of the hormone recorded in response to intensities approaching 
VO2max (90%-95% VO2max). Exercise duration and load also 
seem to affect the hepcidin response, and higher hepcidin 
concentrations have been detected for longer exercise durations. 
Finally, although only scarcely addressed, it does not seem that 
the modality of exercise is too important in the hepcidin response 
to exercise. 
- The few investigations that have tried to examine possible 
adaptations of serum hepcidin levels to training have not provided 
sufficiently clear results to draw any firm conclusions. The reason 
for this is interference with other variables (diet, iron status) that 
have shown an effect on hepcidin regulation.
Future Studies
Given the key role played by hepcidin in whole body iron regulation 
and that exercise is able to modulate hepcidin synthesis, the 
response of hepcidin to exercise (modality, intensity, duration, 
frequency) needs to be further examined in detail. The information 
emerging from future studies should help modify training loads 
and/or establish dietary-nutritional regimens designed to 
maintain adequate body iron levels during training periods.
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